The University of California, San Diego (UCSD) was awarded a $197,576 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The grant, titled "CORTICAL INHIBITION AS A BIOMARKER OF RESPONSE IN A COMPARISON OF BILATERAL VERSUS UNILATERAL ACCELERATED THETA BURST STIMULATION FOR SUICIDAL IDEATION IN TREATMENT-RESISTANT DEPRESSION -COMBAT-SI", will fund a randomized, double-blind clinical trial to investigate the use of bilateral accelerated theta burst stimulation (ATBS) compared to unilateral ATBS for treating suicidal ideation in individuals with treatment-resistant depression. The study aims to explore cortical inhibition as a biological target for ATBS treatment and determine the superiority of bilateral ATBS over unilateral ATBS. The grant will be administered over 5 years from September 1, 2024 to August 31, 2029, and will support the applicant's career development objectives in becoming an independent interventional psychiatry physician scientist.
Generated 3/4/25, 4:57 AM